National and Kapodistrian University of Athens
Ο ρόλος της αυτοανοσίας στις απορρίψεις νεφρικών μοσχευμάτων
Abstract
dc:descriptionThe influence of antibodies against angiotensin II type-1 receptor on the outcome of kidney transplantation: a single-center retrospective study. Background: Allo- and autoimmune mechanisms are involved in kidney allograft rejection and loss. This study investigates the impact of anti-angiotensin II type-1 receptor antibodies (anti-AT1RAbs) detected alone or in association with HLA donor specific antibodies (HLA-DSAs) on the outcome of kidney transplantation (KTx).Patients and Methods: Anti-AT1RAbs and HLA-DSAs were detected in 71 kidney transplant (KT) recipients who developed biopsy-proven acute or chronic active T-cell rejection (TCMR) (n = 51) or antibody-mediated rejection (ABMR) (n = 20), forming the rejection group (RG). The control group (CG) included 71 KTx recipients with comparable characteristics without rejection. All patients had been transplanted with negative T/B flow crossmatch (T/BFCXM). The median follow- up period was 3.7 (2.9-5.2) years. Antibodies were determined pre- and periodically post-KTx by Luminex method for HLA-DSAs and enzyme-linked immunosorbent assay for anti-AT1RAbs. Results: Before KTx, 23 (32.4%) patients in the RG, 16 with TCMR and 7 with ABMR, were found anti-AT1RAbs positive versus 11 (15.5%) patients in the CG (p=0.031). Preformed HLA-DSAs, not detected with T/BFCXM, were found in 19 (26.7%) patients in the RG as compared to 6 (8.4%) in the CG (p=0.010). Simultaneous detection of preformed anti-AT1RAbs and HLA-DSAs was found in 5 patients of RG versus 2 of CG (p=0.355). At the time of transplant biopsy, 15 (21.1%) patients, 4 with ABMR and 11 with TCMR, were positive for anti-AT1RAbs. Anti-AT1RAbs and HLA-DSAs were detected simultaneously in 7/15 (46.7%) cases, 3 with ABMR and 4 with TCMR. During the follow-up, 13 (18.3%) patients in the RG, 8 with ABMR and 5 with TCMR, lost their graft as compared to 1 patient (1.4%) in the CG (p=0.001). Six out of 13 (46.2%) RG patients who lost the graft, were found positive for anti-AT1RAbs pretransplant. Patient survival with functioning graft did not differ significantly between anti-AT1RAbs-positive and -negative KT recipients (log-rank p=0.88). Simultaneous detection of anti-ATR1Abs and HLA-DSAs did not have a significant influence on patient survival with functioning graft (log-rank p=0.96). Graft function at the end of follow-up was better, but not significantly, in anti-AT1RAbs-negative patients, with serum creatinine 1.48 [1.20-1.98] mg/dL and eGFR (CKD-EPI) 48.5 [33.5-59.0] ml/min/1.73m2, as compared to anti-AT1RAbs-positive ones who had serum creatinine 1.65 [1.24-2.02] mg/dL (p=0.394) and eGFR (CKD-EPI) 47.0 [34.8-60.3] ml/min/1.73m2 (p=0.966). Conclusions: Αnti-AT1RAbs detection pretransplant characterizes KT recipients at increased risk of cellular or antibody-mediated rejection. Furthermore, anti-AT1RAbs, detected alone or simultaneously with HLA-DSAs, appear to be associated with impaired graft function, but their role in graft survival has not been documented in this study. Screening for these antibodies appears to complement pretransplant immunological risk assessment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Filiopoulos, Vasileios
- Φιλιόπουλος, Βασίλειος
Subjects
dc:subject × 16- Μεταμόσχευση νεφρού
- Απόρριψη αλλομοσχεύματος
- Λειτουργία μοσχεύματος
- Αντισώματα έναντι του υποδοχέα τύπου 1 της αγγειοτενσίνης ΙΙ
- Αντισώματα έναντι non-HLA αντιγόνων
- Kidney transplantation
- Rejection
- Graft function
- Anti-angiotensin II type 1 receptor antibodies
- Non-HLA antibodies
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Νεφρολογία
- Clinical Medicine
- Medical and Health Sciences
- Nephrology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54571